Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GS-1811 |
Trade Name | |
Synonyms | GS1811|GS 1811|JTX 1811|JTX1811|JTX-1811 |
Drug Descriptions |
GS-1811 is a monoclonal antibody targeted against CCR8, which potentially induces antibody-dependent cell mediated cytotoxicity (ADCC) and depletion of tumor-infiltrating regulatory T cells (Tregs) (Cancer Res 2020;80(16 Suppl):Abstract nr 4532). |
DrugClasses | CCR8 Antibody 9 |
CAS Registry Number | NA |
NCIT ID | C183159 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GS-1811 | GS-1811 | 0 | 1 |
GS-1811 + Pembrolizumab | GS-1811 Pembrolizumab | 0 | 1 |